世界の外反母趾矯正システム市場2022-2030:製品別(インプラント&付属品、ウェアラブル)、最終用途別(病院、外来センター、専門センター)、地域別

【英語タイトル】Bunion Correction Systems Market Size, Share & Trends Analysis Report By Product (Implants & Accessories, Wearables), By End Use (Hospitals, Ambulatory Centers, Specialty Centers), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV22NV016)・商品コード:GRV22NV016
・発行会社(調査会社):Grand View Research
・発行日:2022年10月31日
・ページ数:80
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Grand View Research社は、世界の外反母趾矯正システム市場規模が、2022年から2030年の間に年平均6.9%成長し、2030年までに12億ドルに達すると予測しています。当調査レポートでは、外反母趾矯正システムの世界市場について総合的に調査・分析を行い、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別(インプラント&付属品、ウェアラブル)分析、最終用途別(病院、外来センター、専門センター)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況、企業情報などの構成でまとめています。なお、当書に掲載されている企業情報には、Stryker Corporation、Arthrex, Inc.、Zimmer Biomet Holdings, Inc.、Wright Medical Technology, Inc.、Extremity Medical, LLC.、Acumed, LLC.、De Puy Synthes、CrossRoads Extremity Systems、BioPro, Inc.、Orthofix Holdings Incなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界の外反母趾矯正システム市場規模:製品別
- 外反母趾用インプラント&付属品の市場規模
- 外反母趾用ウェアラブル製品の市場規模
・世界の外反母趾矯正システム市場規模:最終用途別
- 病院における市場規模
- 外来センターにおける市場規模
- 専門センターにおける市場規模
・世界の外反母趾矯正システム市場規模:地域別
- 北米の外反母趾矯正システム市場規模
- ヨーロッパの外反母趾矯正システム市場規模
- アジア太平洋の外反母趾矯正システム市場規模
- 中南米の外反母趾矯正システム市場規模
- 中東・アフリカの外反母趾矯正システム市場規模
・競争状況
・企業情報

Bunion Correction Systems Market Growth & Trends

The global bunion correction systems market size is expected to reach USD 1.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.9 % from 2023 – 2030. The rising prevalence of bunions combined with an increasing number of procedures to treat the condition globally are expected to propel the market growth. Bunion correction systems are used to treat bunion, a foot deformity that occurs at the metatarsophalangeal joint. The increasing prevalence of the condition among the adult population is a key factor that is projected to positively impact market growth.

For instance, according to an article by NCBI, dated December 2021, the prevalence of bunion among the population was 24.9%. Moreover, increasing number of people undergoing surgeries to treat the condition is expected to increase demand for correction systems during the forecast period. For instance, according to an article by Private Clinic, about 1,200 bunion correction procedures are performed every year in the U.K. and Italy. The article also states that the procedures have a success rate of about 98%, which is expected to increase the demand for correction systems.

Moreover, changing lifestyle and an increased working population in developed and developing countries is expected to further contribute to market growth. The use of improper-fitting shoes which causes deformity in the foot anatomy and the growing prevalence of arthritis among the global population are other key factors that are anticipated to boost the market growth. According to an article by Mayoclinic, bunions can be associated with some types of arthritis especially inflammatory arthritis such as rheumatoid arthritis. Rheumatoid arthritis causes inflammation in the joints which increases the risk of developing a bunion.

Availability of minimally invasive surgery options for correcting the condition is expected to boost the growth of the market. For instance, Re+Line a Bunion Correction Systems by Zimmer Biomet is a minimally invasive compression plate used in bunion correction surgery. The system is designed for easy insertion and medial placement using Guide Technology. Moreover, increasing product approvals by Food and Drug Administration is expected to contribute to the growth of the market. For instance, In June 2019, Treace Medical Concepts Inc. a medical device company received approval for Lapiplasty 3D Bunion Correction Systems designed for pediatric patients above the age of 12. The system is designed to correct all three dimensions of bunion deformity which act as a root cause for the condition.

Rising number of initiatives such as mergers and acquisitions undertaken by key players in the market is expected to boost market growth. For instance, In February 2022, CrossRoads Extremity Systems a foot and ankle company based in Tennessee was acquired by DePuy Synthes. The company has a vast portfolio of implants and instrumentations that is cleared for the lower body. The acquisition will add products such as dynaBunion 4D, miniBunion 3D, and DynaForce Staple Compression Plates under its portfolio.

Bunion Correction Systems Market Report Highlights

• In 2022, the wearables segment held the largest share of 51.9% due to the availability of wearables for different age groups

• In 2022, the hospitals segment contributed a 76.2% share. Factors such as a higher number of people undergoing correction surgeries at hospitals positively contributed to the segment growth

• In 2022, North America held the largest revenue share of 52.7% due to the high prevalence of the condition among the population

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definition
1.3. Research Methodology
1.3.1. Information Procurement
1.3.1.1. Purchased database
1.3.1.2. GVR’s internal database
1.3.2. Primary Research
1.4. Research Scope and Assumptions
1.5. List to Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. Bunion Correction Systems Market
Chapter 3. Bunion Correction Systems Market Variables, Trends, & Scope
3.1. Penetration and Growth Prospect Mapping
3.2. Market Dynamics
3.3. Bunion Correction Systems Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.3. Major Deals & Strategic Alliances Analysis
Chapter 4 Bunion Correction Systems Market: Product Estimates & Trend Analysis
4.1. Definitions & Scope
4.2. Bunion Correction Systems Market: Product Movement Analysis, 2021 & 2030 (USD Million)
4.3. Implants & Accessories
4.3.1. Implants & Accessories market estimates and forecasts, 2017 – 2030 (USD Million)
4.4. Wearables
4.4.1. Wearables market estimates and forecasts, 2017 – 2030 (USD Million)
Chapter 5. Bunion Correction Systems Market: End Use Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Bunion Correction Systems Market: End-use Movement Analysis, 2021 & 2030 (USD Million)
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2017 – 2030 (USD Million)
5.4. Ambulatory Centers
5.4.1. Ambulatory Centers market estimates and forecasts, 2017 – 2030 (USD Million)
5.5. Specialty Centers
5.5.1. Specialty Centers market estimates and forecasts, 2017 – 2030 (USD Million)
Chapter 6. Bunion Correction Systems Market: Regional Estimates & Trend Analysis
6.1. Regional Market Snapshot
6.2. Bunion Correction Systems Market: Regional Movement Analysis
6.3. North America
6.3.1. North America market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.3.2. North America market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.3.3. U.S.
6.3.3.1. U.S. market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.3.3.2. U.S. market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.3.4. Canada
6.3.4.1. Canada market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.3.4.2. Canada market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.4. Europe
6.4.1. Europe market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.4.2. Europe market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Germany market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.4.3.2. Germany market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.4.4. U.K.
6.4.4.1. U.K. market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.4.4.2. U.K. market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.4.5. France
6.4.5.1. France market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.4.5.2. France market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.4.6. Italy
6.4.6.1. Italy market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.4.6.2. Italy market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.4.7. Spain
6.4.7.1. Spain market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.4.7.2. Spain market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.5.2. Asia Pacific market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Japan market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.5.3.2. Japan market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.5.4. China
6.5.4.1. China market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.5.4.2. China market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.5.5. India
6.5.5.1. India market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.5.5.2. India market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.5.6. Australia
6.5.6.1. Australia market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.5.6.2. Australia market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. South Korea market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.5.7.2. South Korea market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.6.2. Latin America market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.6.3. Brazil
6.6.3.1. Brazil market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.6.3.2. Brazil market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.6.4. Mexico
6.6.4.1. Mexico market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.6.4.2. Mexico market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.6.5. Argentina
6.6.5.1. Argentina market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.6.5.2. Argentina market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.7. MEA
6.7.1. MEA market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.7.2. MEA market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. South Africa market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.7.3.2. South Africa market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Saudi Arabia market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.7.4.2. Saudi Arabia market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
6.7.5. UAE
6.7.5.1. UAE market estimates and forecasts, by product 2017 – 2030 (USD Million)
6.7.5.2. UAE market estimates and forecasts, by end-use 2017 – 2030 (USD Million)
Chapter 7. Bunion Correction Systems Market – Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Competition Categorization
7.3. Vendor Landscape
7.3.1. Public Companies
7.3.2. Private Companies
Chapter 8. Company Profiles
8.1. Stryker Corporation
8.1.1. Company overview
8.1.2. Financial performance
8.1.3. Product benchmarking
8.1.4. Strategic initiatives
8.2. Arthrex, Inc.
8.2.1. Company overview
8.2.2. Financial performance
8.2.3. Product benchmarking
8.2.4. Strategic initiatives
8.3. Zimmer Biomet Holdings, Inc.
8.3.1. Company overview
8.3.2. Financial performance
8.3.3. Product benchmarking
8.3.4. Strategic initiatives
8.4. Wright Medical Technology, Inc.
8.4.1. Company overview
8.4.2. Financial performance
8.4.3. Product benchmarking
8.4.4. Strategic initiatives
8.5. Extremity Medical, LLC.
8.5.1. Company overview
8.5.2. Financial performance
8.5.3. Product benchmarking
8.5.4. Strategic initiatives
8.6. Acumed, LLC.
8.6.1. Company overview
8.6.2. Financial performance
8.6.3. Product benchmarking
8.6.4. Strategic initiatives
8.7. De Puy Synthes
8.7.1. Company overview
8.7.2. Financial performance
8.7.3. Product benchmarking
8.7.4. Strategic initiatives
8.8. CrossRoads Extremity Systems
8.8.1. Company overview
8.8.2. Financial performance
8.8.3. Product benchmarking
8.8.4. Strategic initiatives
8.9. BioPro, Inc.
8.9.1. Company overview
8.9.2. Financial performance
8.9.3. Product benchmarking
8.9.4. Strategic initiatives
8.10. Orthofix Holdings Inc.
8.10.1. Company overview
8.10.2. Financial performance
8.10.3. Product benchmarking
8.10.4. Strategic initiatives
8.11. OrthoHelix Surgical Designs
8.11.1. Company overview
8.11.2. Financial performance
8.11.3. Product benchmarking
8.11.4. Strategic initiatives



★調査レポート[世界の外反母趾矯正システム市場2022-2030:製品別(インプラント&付属品、ウェアラブル)、最終用途別(病院、外来センター、専門センター)、地域別] (コード:GRV22NV016)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の外反母趾矯正システム市場2022-2030:製品別(インプラント&付属品、ウェアラブル)、最終用途別(病院、外来センター、専門センター)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆